CFRA has a buy rating on the Pfizer (PFE) stock with a $45 price target. They also have a buy rating on Johnson & Johnson (JNJ) with a $177 price target, as well as Novavax (NVAX) with a $200 price target. Sel Hardy examines the outlook for these pharmaceutical stocks.
The Watch List
12 May 2021
SHARE
Trading 360
23 Feb 2022
Morning Trade Live
18 Mar 2022
Market On Close
23 Feb 2022
Trading 360
28 Apr 2022
Morning Trade Live
31 Mar 2022
Trading 360
19 Apr 2022